Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
GezKAUX6NLxWxyPM
Listen
